H
Hyperfine
Health Tech & Medtech · Guilford, United States · Founded 2014
Portable, ultra-low field MR brain imaging system enabling timely clinical decisions at the point of care MoreLess
Hyperfine, Inc. is a pioneering health technology company that has developed the Swoop system, the first FDA-cleared, portable, ultra-low field magnetic resonance imaging (MRI) system. The Swoop system is designed to bring MR brain imaging directly to the patient's bedside, particularly in intensive care units, thereby eliminating the need to transport critically ill patients to radiology departments. This innovation allows for timelier treatment decisions, quicker patient discharges, and more efficient use of hospital staff and resources. The system's open and safe design also enables family members to stay close and provide comfort during imaging procedures. Hyperfine's primary clients include hospitals, clinics, and other healthcare facilities that require accessible and efficient diagnostic imaging solutions. The company operates in the global healthcare market, focusing on improving patient care through advanced imaging technology. Hyperfine generates revenue by selling its Swoop system and related services to healthcare providers. The business model is centered around providing a cost-effective, portable MRI solution that enhances clinical decision-making and patient outcomes.
Keywords: portable MRI, ultra-low field, brain imaging, point-of-care, FDA-cleared, healthcare technology, patient care, diagnostic imaging, intensive care, clinical efficiency.
Company overview
Hyperfine company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2014
- Headquarters
- Guilford, United States
- Employees
- 121
- Open positions
- None listed
- Dealroom signal
- 68.4
Valuation & funding
Hyperfine funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBTDebt | Mar 2026 | $0 | — | Horizon Technology Finance Corporation | ↗ |
| GRANTOther financing | Nov 2025 | $3.7M | — | Bill & Melinda Gates Foundation | ↗ |
| IPOOther financing | Oct 2025 | $18M | $103M | Undisclosed | ↗ |
| POST IPO EQUITYOther financing | Feb 2025 | $6M | — | Undisclosed | ↗ |
| GRANTOther financing | May 2023 | $3M | — | Bill & Melinda Gates Foundation | ↗ |
| SPAC PRIVATE PLACEMENTOther financing | Jul 2021 | Bain Capital · Deerfield · Avidity Partners · HealthCor Management | — | ||
| SPAC IPOOther financing | Jul 2021 | HealthCor Catalio Acquisition Corp | — | ||
| SERIES DOther financing | Feb 2021 | Altium Capital · Colle Capital Partners · Huami Technology · Axiom Associates | — | ||
| GRANTOther financing | Nov 2020 | Bill & Melinda Gates Foundation | — | ||
| SERIES COther financing | Jan 2017 | Undisclosed | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $20M | +48.6% | −$31M | -154.9% |
| 2025 | $14M | +5.2% | −$37M | -271.5% |
| 2024 | $13M | +16.8% | −$42M | -327.5% |
| 2023 | $11M | +61.9% | −$47M | -426.6% |
| 2022 | $6.8M | +355.5% | −$73M | -1069.3% |
| 2021 | $1.5M | +408.8% | −$64M | -4287.6% |
| 2020 | $294K | — | −$23M | -7891.8% |
Growth signals
Hyperfine website traffic
Latest recorded traffic for Hyperfine is 10K monthly website visits, up 185.7% over the last three months. Hyperfine's team grew 0% over the past year.
Comparisons
Hyperfine compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Hyperfine's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Hyperfine has talent and traffic
team presence
In the news
Latest news about Hyperfine
Recent press, funding announcements, and product moves mentioning Hyperfine — open to read from the original sources.
Market sentiment
What the market is saying about Hyperfine
An AI-synthesized read of the highest-engagement posts about Hyperfine on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hyperfine’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





















